These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 23011726)

  • 41. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Z-Guggulsterone attenuates cognitive defects and decreases neuroinflammation in APPswe/PS1dE9 mice through inhibiting the TLR4 signaling pathway.
    Liu J; Lin Y; Yang Y; Guo Y; Shang Y; Zhou B; Liu T; Fan J; Wei C
    Biochem Pharmacol; 2022 Aug; 202():115149. PubMed ID: 35714682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain.
    Sano T; Ochiai T; Nagayama T; Nakamura A; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    J Neurosci; 2023 Oct; 43(43):7226-7241. PubMed ID: 37699718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
    Solberg NO; Chamberlin R; Vigil JR; Deck LM; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Bisoffi M; Severns V; Vander Jagt DL; Sillerud LO
    J Alzheimers Dis; 2014; 40(1):191-212. PubMed ID: 24413613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
    Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
    Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice.
    Wang P; Su C; Feng H; Chen X; Dong Y; Rao Y; Ren Y; Yang J; Shi J; Tian J; Jiang S
    Int J Immunopathol Pharmacol; 2017 Mar; 30(1):25-43. PubMed ID: 28124574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
    Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
    Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active Amyloid-β Vaccination Results in Epigenetic Changes in the Hippocampus of an Alzheimer's Disease-Like Mouse Model.
    Lardenoije R; van den Hove DLA; Jung SE; Havermans M; Blackburn P; Liu B; Rutten BPF; Lemere CA
    Curr Alzheimer Res; 2019; 16(9):861-870. PubMed ID: 31453788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice.
    Tsai-Teng T; Chin-Chu C; Li-Ya L; Wan-Ping C; Chung-Kuang L; Chien-Chang S; Chi-Ying HF; Chien-Chih C; Shiao YJ
    J Biomed Sci; 2016 Jun; 23(1):49. PubMed ID: 27350344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
    Wang Y; Tang XC; Zhang HY
    J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.
    Rajasekar N; Nath C; Hanif K; Shukla R
    Mol Neurobiol; 2017 Oct; 54(8):6507-6522. PubMed ID: 27730514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease].
    Lysikova EA; Kuzubova EV; Radchenko AI; Patrakhanov EA; Chaprov KD; Korokin MV; Deykin AV; Gudyrev OS; Pokrovskii MV
    Mol Biol (Mosk); 2023; 57(1):85-94. PubMed ID: 36976741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease.
    Hölscher C
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S47-54. PubMed ID: 24529525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.
    Ettcheto M; Sánchez-López E; Pons L; Busquets O; Olloquequi J; Beas-Zarate C; Pallas M; García ML; Auladell C; Folch J; Camins A
    Redox Biol; 2017 Oct; 13():345-352. PubMed ID: 28646794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway.
    Xie Y; Zheng J; Li S; Li H; Zhou Y; Zheng W; Zhang M; Liu L; Chen Z
    Biochem Pharmacol; 2021 Jun; 188():114578. PubMed ID: 33895160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.